Researchers have decoded the 3D structure of the Huntingtin protein. The discovery may help develop new treatments for Huntington's disease.
Rockefeller University researchers reveal Huntington's neurons are much larger than healthy cells.
UCL researchers report clinical trials of IONIS-HTTRx have shown success in reducing the huntinting protein in the nervous system of those with Huntington's disease. The drug is safe and well tolerated by human patients, the researchers note.
Findings may explain how neurodegenerative diseases spread throughout the brain and disrupt normal functions. Additionally, treatment for one disease could possibly work for the other two also.
Researchers discover a link between neural tube defects and neurodegenerative diseases.
Researchers report Huntington's disease is not only a neurodegenerative disease, it is also a disease that affects muscle tissues.
Researchers have identified a novel type of cell death associated with Huntington's disease.
Researchers reveal how a repeating nucleotide sequence in the gene for a mutant protein may trigger Huntington's disease.
A new study reveals a new molecular mechanism for Huntington's disease.
Researchers have identified several new biological markers to measure the progression of the inherited neurodegenerative disorder Huntington's disease.
Researchers have discovered a way in which it could be possible to stop proteins from triggering energy failure inside nerve cells in those affected by Huntington's disease.
Researchers have identified a protein that can turn off the Huntingtin gene's expression.
